Replies to post #18432 on COSCIENS Biopharma Inc (CSCI)

[livendi]

long term u cant lose imo,wat too many different catalysts coming and more than 1 for unmet needs,it could get a little ugly till then but not much more than what has happened already,again what will pps be when pedi test is approved,same for the 2 phase 3 trials in usa for cancer cachexia and tbi,what will pps be if fda approves 1 or even both,the pps will skyrocketand eu and row will follow fda like they did the adult test and we own all of macrilen other uses except n america where novo owns the rights,still it will increase macrilen sales bigtime of which we get %,im telling u imo this will fly on these approvals,gain they are for unmet needs and thats not counting lou gehrigs disease and every other new licensing deaals aezs has,when i think the bottom is reached i will load the boat and wait it out till it hits